YME1L1 and pancreatic ductal adenocarcinoma: Recent studies have elucidated the oncogenic potential of YME1L in various cancer types, such as pancreatic ductal adenocarcinoma (PDAC), glioma and non-small cell lung cancer (NSCLC) [23–25].